ADIPOQ and diabetes mellitus: Pioglitazone, a drug used in the treatment of diabetes, has been shown to increase adiponectin by acting on PPARγ, which in turn activates AMP kinase, thereby decreasing blood glucose levels (Janani et al., 2014).